Meeting Insights

Doris M. Ponce, MD, program director of GVHD at Memorial Sloan Kettering Cancer Center in New York City, shared her insights from the 2022 ASH Annual Meeting and Exposition.

Doris M. Ponce, MD, a hematologic oncologist from Memorial Sloan Kettering Cancer Center (MSKCC) in New York, provided insight into and key takeaways from research on graft-vs-host disease (GVHD) presented at the meeting.

Mark C. Walters, MD, discusses research on thalassemias presented at the 62nd ASH Annual Meeting & Exposition.